Abstract
Medical pruritus is characterized by itch secondary to systemic causes, which typically presents in the absence of primary skin lesions. Distinguishing medical pruritus from primary dermatologic pruritus on skin examination is challenging, given that some forms of dermatologic pruritus have very few or no primary lesions, or the primary lesions are obscured by secondary lesions. As a consequence of such diagnostic challenge, pruritus presentation often remains “idiopathic.” Unfortunately, underlying systemic diagnoses may be associated with significant morbidity and mortality, such as lymphoproliferative diseases or HIV infection. This highlights the importance of developing a systematic approach to patients presenting with medical pruritus. Therefore, patients presenting with generalized pruritus without primary skin lesions should be evaluated for systemic disorders through detailed patient history and physical examination, which could guide further laboratory investigations. If an underlying cause of pruritus is not identified, patients should be re-evaluated periodically with a review of systems and physical examination. The aim of this review is to discuss systemic causes of itch and propose a practical, evidence-based approach to the work-up of medical pruritus.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol. 2011;1(3):177–84.
Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol. 2010;49(1):1–11.
Kremer AE, Bolier R, van Dijk R, Oude Elferink RP, Beuers U. Advances in pathogenesis and management of pruritus in cholestasis. Dig Dis. 2014;32(5):637–45.
Beard MP, Millington GW. Recent developments in the specific dermatoses of pregnancy. Clin Exp Dermatol. 2012;37(1):1–4 (quiz 5).
Bunchorntavakul C, Reddy KR. Pruritus in chronic cholestatic liver disease. Clin Liver Dis. 2012;16(2):331–46.
Etter L, Myers SA. Pruritus in systemic disease: mechanisms and management. Dermatol Clin. 2002;20(3):459–72 (vi-vii).
Quarneti C, Muratori P, Lalanne C, Fabbri A, Menichella R, Granito A, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int. 2015;35(2):636–41.
Varadi DP. Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin. Arch Dermatol. 1974;109(5):678–81.
Murphy GM, Ross A, Billing BH. Serum bile acids in primary biliary cirrhosis. Gut. 1972;13(3):201–6.
Ghent CN. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. Am J Gastroenterol. 1987;82(2):117–8.
Summerfield JA. Naloxone modulates the perception of itch in man. Br J Clin Pharmacol. 1980;10(2):180–3.
Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ. 1988;297(6662):1501–4.
Eisendle K, Muller H, Ortner E, Talasz H, Graziadei I, Vogel W, et al. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. J Gastroenterol Hepatol. 2011;26(4):716–21.
Mettang T, Fritz P, Weber J, Machleidt C, Hubel E, Kuhlmann U. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol. 1990;34(3):136–41.
Ponticelli C, Bencini PL. Pruritus in dialysis patients: a neglected problem. Nephrol Dial Transplant. 1995;10(12):2174–6.
Stahle-Backdahl M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol Suppl (Stockh). 1989;145:1–38.
Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis. 2007;50(1):11–20.
Pisoni RL, Wikstrom B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–505.
Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus–new perspectives and insights from recent trials. Nephrol Dial Transplant. 2002;17(9):1558–63.
Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med. 1979;91(1):17–21.
Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant. 2004;19(7):1895–901.
Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron. 1994;67(3):270–3.
Kumagai H, Ebata T, Takamori K, Miyasato K, Muramatsu T, Nakamoto H, et al. Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients. Am J Nephrol. 2012;36(2):175–83.
Zucker I, Yosipovitch G, David M, Gafter U, Boner G. Prevalence and characterization of uremic pruritus in patients undergoing hemodialysis: uremic pruritus is still a major problem for patients with end-stage renal disease. J Am Acad Dermatol. 2003;49(5):842–6.
Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci. 2001;4(1):72–7.
Masmoudi A, Hajjaji Darouiche M, Ben Salah H, Ben Hmida M, Turki H. Cutaneous abnormalities in patients with end stage renal failure on chronic hemodialysis. A study of 458 patients. J Dermatol Case Rep. 2014;8(4):86–94.
Isaacs NJ, Ertel NH. Urticaria and pruritus: uncommon manifestations of hyperthyroidism. J Allergy Clin Immunol. 1971;48(2):73–81.
Graham DT, Goodell H, Wolff HG. Studies on pain: the relation between cutaneous vasodilatation, pain threshold and spontaneous itching and pain. Am J Med Sci. 1957;234(4):420–30.
Lewiecki EM, Rahman F. Pruritus. A manifestation of iron deficiency. JAMA. 1976;236(20):2319–20.
Valsecchi R, Cainelli T. Generalized pruritus: a manifestation of iron deficiency. Arch Dermatol. 1983;119(8):630.
Sato S. Iron deficiency: structural and microchemical changes in hair, nails, and skin. Semin Dermatol. 1991;10(4):313–9.
Kluger N, Raison-Peyron N, Rigole H, Bessis D, Blanc F, Guillot B. Generalized pruritus revealing hereditary haemochromatosis. Acta Derm Venereol. 2007;87(3):277.
Polat M, Oztas P, Ilhan MN, Yalcin B, Alli N. Generalized pruritus: a prospective study concerning etiology. Am J Clin Dermatol. 2008;9(1):39–44.
Krajnik M, Zylicz Z. Pruritus in advanced internal diseases Pathogenesis and treatment. Neth J Med. 2001;58(1):27–40.
Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther. 2010;23(6):590–6.
Pavlidis NA, Klouvas G, Tsokos M, Bai M, Moutsopoulos HM. Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders–a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma. 1995;16(5–6):477–82.
Diehn F, Tefferi A. Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br J Haematol. 2001;115(3):619.
Siegel FP, Tauscher J, Petrides PE. Aquagenic pruritus in polycythemia vera: characteristics and influence on quality of life in 441 patients. Am J Hematol. 2013;88(8):665–9.
Blanes M, Belinchon I, Portilla J, Betlloch I, Reus S, Sanchez-Paya J. Pruritus in HIV-infected patients in the era of combination antiretroviral therapy: a study of its prevalence and causes. Int J STD AIDS. 2012;23(4):255–7.
Lee HG, Stull C, Yosipovitch G. Psychiatric disorders and pruritus. Clin Dermatol. 2017;35(3):273–80.
Rowe B, Yosipovitch G. Malignancy-associated pruritus. Eur J Pain. 2016;20(1):19–23.
Bakker CV, Terra JB, Pas HH, Jonkman MF. Bullous pemphigoid as pruritus in the elderly: a common presentation. JAMA Dermatol. 2013;149(8):950–3. https://doi.org/10.1001/jamadermatol.2013.756.
Author information
Authors and Affiliations
Contributions
All authors were involved in the development, research, writing, and editing of this manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
- Given the morbidity and mortality associated with underlying systemic causes of medical pruritis, it is important to develop an evidence-based approach to patients presenting with generalized itch.
- Most common diagnoses to consider in patients with medical pruritis include cholestatic pruritus, chronic kidney disease-associated pruritus, hyperthyroidism, iron disorders, lymphoproliferative disorders, myeloproliferative disorders, and HIV infection.
- Detailed patient history, physical examination, and laboratory investigations are required to diagnose the underlying systemic cause of medical pruritis.
This article is part of the Topical Collection on Medicine.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Haxho, F., Shelley, A., Lytvyn, Y. et al. Approach and Work-Up for Medical Pruritus. SN Compr. Clin. Med. 4, 236 (2022). https://doi.org/10.1007/s42399-022-01313-y
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-022-01313-y